Literature DB >> 9048929

A high-frequency polymorphism of NADH-cytochrome b5 reductase in African-Americans.

M M Jenkins1, J T Prchal.   

Abstract

NADH-cytochrome b5 reductase (b5R) is a member of a flavoenzyme family of dehydrogenases-electron transferases that participates in the transfer of electrons from the NADH generated in glycolysis to cytochrome b5. b5R is involved in the steady-state reduction of methemoglobin to hemoglobin in erythrocytes and is also involved in lipid metabolism in other cell types. In a search for mutations of the b5R gene in two unrelated African-American families, a high-frequency polymorphism was detected in the propositi from both families, as well as unrelated normal controls, consisting of a C-to-G transversion in exon 5 that changes threonine to serine at codon 116 (T116S). This is the first polymorphism found in the b5R gene. Using allele-specific PCR on the two propositi, their family members, and unselected populations of African-American, Caucasian, Asian, Indo-Aryan, and Arabic individuals, the C/G polymorphism was found in 26 of 112. African-American chromosomes (allele frequency = 0.23), but not in 108 Caucasian, 46 Asian, 44 Indo-Aryan, or 14 Arabic chromosomes. In preliminary studies, this polymorphism did not correlate with b5R enzyme activity or cause any disease phenotype. It remains to be determined whether this African-specific polymorphism that apparently originated recently in human evolution provides any special survival advantage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048929     DOI: 10.1007/s004390050347

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

1.  Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.

Authors:  Keelia Rhoads; James C Sacco; Nicholas Drescher; Amos Wong; Lauren A Trepanier
Journal:  Toxicol Sci       Date:  2011-03-29       Impact factor: 4.849

2.  Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.

Authors:  James C Sacco; Lauren A Trepanier
Journal:  Pharmacogenet Genomics       Date:  2010-01       Impact factor: 2.089

3.  Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress.

Authors:  Brittany G Durgin; Katherine C Wood; Scott A Hahn; Brenda McMahon; Jeffrey J Baust; Adam C Straub
Journal:  J Mol Cell Cardiol       Date:  2021-09-15       Impact factor: 5.000

4.  The CYB5R3c .350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.

Authors:  Victor R Gordeuk; Binal N Shah; Xu Zhang; Philip E Thuma; Stenford Zulu; Rodgers Moono; N Scott Reading; Jihyun Song; Yingze Zhang; Mehdi Nouraie; Andrew Campbell; Caterina P Minniti; Sohail R Rana; Deepika S Darbari; Gregory J Kato; Mei Niu; Oswaldo L Castro; Roberto Machado; Mark T Gladwin; Josef T Prchal
Journal:  Am J Hematol       Date:  2020-09-23       Impact factor: 10.047

5.  Phase I/II evaluation of the prophylactic antimalarial activity of pafuramidine in healthy volunteers challenged with Plasmodium falciparum sporozoites.

Authors:  Myaing M Nyunt; Craig W Hendrix; Rahul P Bakshi; Nirbhay Kumar; Theresa A Shapiro
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

6.  Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice.

Authors:  Katherine C Wood; Brittany G Durgin; Heidi M Schmidt; Scott A Hahn; Jeffrey J Baust; Tim Bachman; Dario A Vitturi; Samit Ghosh; Solomon F Ofori-Acquah; Ana L Mora; Mark T Gladwin; Adam C Straub
Journal:  Blood Adv       Date:  2019-12-10

7.  Structural characterization of single nucleotide variants at ligand binding sites and enzyme active sites of human proteins.

Authors:  Kazunori D Yamada; Hafumi Nishi; Junichi Nakata; Kengo Kinoshita
Journal:  Biophys Physicobiol       Date:  2016-07-14

8.  Loss of cardiomyocyte CYB5R3 impairs redox equilibrium and causes sudden cardiac death.

Authors:  Nolan T Carew; Heidi M Schmidt; Shuai Yuan; Joseph C Galley; Robert Hall; Helene M Altmann; Scott A Hahn; Megan P Miller; Katherine C Wood; Bethann Gabris; Margaret C Stapleton; Sean Hartwick; Marco Fazzari; Yijen L Wu; Mohamed Trebak; Brett A Kaufman; Charles F McTiernan; Francisco J Schopfer; Placido Navas; Patrick H Thibodeau; Dennis M McNamara; Guy Salama; Adam C Straub
Journal:  J Clin Invest       Date:  2022-09-15       Impact factor: 19.456

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.